Rare diseases
Investigational molecules
Locations
172 conditions with trials, the busiest first
481 trials across Europe, recruiting first
Study on Spironolactone for Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD)
FranceStudy on Spironolactone for Maintaining Sinus Rhythm in Hypertensive Patients with Atrial Fibrillation and Preserved Heart Function
FranceStudy on Colchicine for Treating Patients with Inflammatory Cardiomyopathy
ItalyA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
BulgariaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
AustriaStudy of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan
CzechiaEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
BulgariaStudy on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure
PolandStudy on Ivabradine for Preventing Heart Injury in Patients with Atherosclerosis Undergoing Noncardiac Surgery
PolandStudy of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease
AustriaStudy on Dapagliflozin to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
PolandStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
AustriaThe therapies tested most often in Cardiac disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
